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Hospital in Addis Ababa, Ethiopia  
 




Background: Breast cancer is the major cause of cancer deaths among women globally. Socio-demographic and 
haematological characteristics are among the determinants of breast cancer, and these characteristics are supposed 
to be monitored during early diagnosis and treatment of cases.  
Objective: The objective of this study was to assess socio-demographic and haematological profile of patients 
with breast cancer at Tikur Anbessa Specialized Hospital. 
Methods: Case controlled study was conducted among 230 cases and 230 controls from May 2018 to June 2019. 
Descriptive analysis was made to assess socio-demographic characteristics and independent sample t- test was 
performed to compare the mean haematological parameters.  
Results: The mean age was 42.8 + 12.1 years and 39.3 + 11.1 years for cases and controls, respectively. About 
43.5% of the cases and 14.8% of the controls were not able to read and write. About 76.1% of the cases and 67.4% 
of the controls were married. The mean values of Haemoglobin, Red Blood cell, Packed Cell Volume for the cases 
were 13.1 + 1.6g/dl; 4.6 + 0.54x1012/L; and 38.7 + 4.5 %, respectively. These were significantly lower than those 
of the controls (14.0 + 1.3g/dl, 4.8 + 0.47 x 1012/L, 40.5 + 3.5%, respectively). Mean platelet count was higher 
among the cases, whereas total White Blood cell count was almost similar. 
Conclusion and recommendations: Majority of the cases were less than 40 years of age and were not able to 
read and write. Most of the RBC parameters of cases were significantly lower than the controls. Therefore, 
attention should be given for exposed groups and those with the designated haematological abnormalities. [Ethiop. 
J. Health Dev. 2020; 35(2):000-000] 
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Background 
Breast cancer is the major cause of cancer deaths in 
women [1]. Though significant progress has been made 
in breast cancer prognosis and survival, the disease is 
still the main cause of death among women in low- and 
middle-income countries [1-3]. There is increase in 
magnitude of cancer in many African countries, but 
cancer controlling programs are still extremely low [4].   
 
Socio-demographic factors are linked with breast 
cancer. According to findings from European countries 
including Sweden and Norway, higher socioeconomic 
status of women was significantly associated with 
breast cancer incidence [5]. Age, marital status, 
employment status, as well as educational status were 
determinants of breast cancer incidence as 
demonstrated by other studies from Iraq [6,7]. 
 
Age, marital status, employment status, as well as low 
educational status were determinants of breast cancer 
incidence as demonstrated by other studies from Iraq 
[6-7]. A WHO survey conducted in low-income 
countries found that country health spending, health 
care access, rural residence and socioeconomic status 
were significant factors for cancer screening [8]. In 
Nigeria, socio-demographic factors increased the risk 
of late presentation [9].  
 
Breast cancer is the leading cause of morbidity and 
mortality in Ethiopia, too, gaining conducive 
opportunities due to long patient delay and advanced 
stage at diagnosis [10] Trend of breast cancer is 
increasing, and it is the most predominant type of 
cancer in Ethiopia [11, 12]. In general, cancer 
contributes for 5.8% of the total national mortality 
[13]. It is also found that breast cancer is highly posing 
a significant public health problem in Ethiopia [14]. On 
the other hand, most cancer patients have poor 
awareness. As a result, majority of patients seek 
treatment at advanced and incurable stage of the 
disease [15]. 
 
Haematological abnormalities are common features to 
be considered in breast cancer patients. Those 
parameters could be used as one of the important 
biochemical tools in the diagnosis of other co-
morbidities and treatment monitoring in breast cancer 
patients [16]. Studies indicate haematological 
parameters as important investigations that are useful 
prognostic factors for evaluating the accuracy of risk 
stratification in breast cancer patients [17, 18]. Studies 
done in Nigeria showed that most of the 
haematological parameters were significantly lower 
among breast cancer patients than among controls [18, 
19]. Hematologic parameters were also significantly 
lower in patients in Iraq [20]. A study in Malaysia 
revealed that 22% of breast cancer patients had 
significantly decreased haemoglobin value [21].  
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Studies in Ethiopia indicated that, at the time of 
diagnosis, 80–90% of patients suffer from advanced 
and incurable cancers [15, 22-24]. Socio-demographic 
factors may have influence on late presentation and 
contribute to neglecting sign and symptoms, illnesses, 
as well as late notifications and treatment delay [9]. 
Since breast cancer is associated with lifestyle, it is 
important to investigate and recognise various socio-
demographic elements of patients with the disease. 
Even though breast cancer incidence has increased 
rapidly in Ethiopia [13], there is still lack of studies 
that investigated socio-demographic and 
haematological profile of breast cancer patients. It is 
important to assess haematological status of breast 
cancer patients at regular intervals during different 
stages of treatment to determine their diagnostic and 
prognostic values, which can help for improved 
management. Therefore, this study was aimed to assess 
socio-demographic and hematologic profiles of patients 
with breast cancer at Tikur Anbessa Specialised 
Hospital.   
 
Materials and Methods 
Study design and period: Hospital-based case control 
study was done at Tikur Anbessa Specialized Hospital 
(TASH), Addis Ababa, Ethiopia. The study was 
conducted from May 2018 to June 2019. Cases and 
controls were matched based on residence within and 
outside Addis Ababa.  
 
Eligibility criteria 
Since breast cancer mainly affects women, only 
women patients and controls aged 18 years and older 
were included in the study. Cases were all newly 
diagnosed breast cancer patients with confirmed 
histology result, no recognizable mental illnesses, and 
no history of chronic illness. On the other hand, 
controls were women accompanying breast cancer 
patients who had no biological relationship with 
selected cases, no history of chronic illness, and who 
were free from breast mass. 
 
Sampling and sample Size determination 
Tikur Anbessa Specialized Hospital was selected for 
the study since it was the only referral centre for cancer 
treatment during the study period. All eligible and 
voluntary breast cancer patients that came to TASH 
during the study period were included as cases and 
controls based on convenient sampling technique.   
 
The sample population of the cases was female breast 
cancer patients referred to TASH Oncology 
department, who fulfilled inclusion criteria and who 
gave informed consent. For the controls, the sample 
population was women caregivers accompanying 
breast cancer patients.  
 
Sample size was calculated using Open Epi by 
assuming old age (>50 years) as a risk factor for breast 
cancer, 80% power, 0.05 significance level at 95% CI, 
and 1:1 ratio of case to control. Percentage of exposed 
among control group was 11.9%, percentage of 
exposed among cases 21.6%, (Ibrahim, 2010), and 
odds ratio of 2.05. Finally, the total sample size was 
460 (230 cases and 230 controls).  
Data collection, management, and analysis 
Prior to data collection, written informed consent was 
obtained from each study participant. Haematological 
parameters of breast cancer patients were recorded 
from their laboratory reports. Eligible controls were 
selected by breast physical examination. Then, 
interview was conducted by experienced nurses. Blood 
sample was collected at the end of each interview and 
the sample was analysed at TASH Laboratory using 
Sysmex KX –21N Haematology analyser. Data was 
analysed by using Statistical Package for Social 
Science (SPSS) version 20 Software. Then, descriptive 
analysis was made to assess socio-demographic 
characteristics of the study participants. Independent 
sample t-test was used to compare mean + standard 
deviation of different haematological parameters. In 
addition, Chi square test was conducted to see 
significant difference of haematological parameters 
between cases and controls. P- values less than 0.05 
were considered statistically significant. 
 
To assess presence of selected haematologic 
abnormalities, the reference range was taken from 
WHO and from the output of CBC SYSMEX KX – 
21N haematology analyser. Regarding anaemia, WHO 
2011 haemoglobin (HB) concentration cut-offs for the 
diagnosis of anaemia and assessment of severity was 
used. As per this assessment, if HB concentration is 
>12gm/dl, there is no anaemia, HB level 10.9 -
11.0gm/dl is associated with mild anaemia, HB 8.0-
10.9 gm/dl suggestive of moderate anaemia and severe 
anaemia is indicated by HB less than 8gm/dl. In 
addition, anaemia was further characterised as 
microcytic and macrocytic based on MCV values; and 
as hypochromic and normochromic anaemia based on 
MCHC values. Leucocyte and platelet values were also 
characterised based on the reference range of 
haematology analyser. When WBC count was less than 
3.7 x 109/L, it was characterised as leucopoenia, 
whereas when the value was greater than 10.4 x109/L, 
it was characterised as leucocytosis. Regarding the 
platelet count, if the platelet count was less than 140 x 
109/L, it was characterised as thrombocytopenia; 
whereas, when the value was greater than 385 x 109/L, 
it was characterised as thrombocytosis. 
 
Data quality control and assurance 
To minimise errors when using hospital controls, 
healthy controls were selected after breast physical 
examination was made. And to facilitate their 
understanding of the issues, questionnaire was prepared 
in English and translated to Amharic. For those who 
did not speak Amharic language, we used care givers 
and nurses as translators. Data collection tools were 
pretested, and training was given for data collectors. 
Daily supervision was made on all questioners 
collected on each day. All collected blood specimens 
were analysed on the same day of sample collection. 
Control samples were analysed before testing actual 
patient samples.  
 
Ethical considerations 
Ethical approval was obtained from Addis Ababa 
University, College of Health Sciences Institutional 
Review Board. Written informed consent was obtained 
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from each respondent. Confidentiality and privacy 
were maintained throughout the study. During selection 
of controls, women who had breast mass were 
consulted by physician and their results were given for 
free to get early diagnosis and treatment. 
 
Results 
Socio-demographic characteristics of the study 
participants: In this study, 230 cases and 230 controls 
were included. Majority (i.e., 70.9%) of the cases and 
75.7% of the controls were urban dwellers. Mean ages 
of the study participants were 42.83 + 12.06 and 39.33 
+ 11.14 years (P < 0.05) for cases and controls, 
respectively. More than half (54.3%) of cases and 
62.2% of the controls were less than 40 years old 
(Table 1).  Regarding marital status, 76.1% of the cases 
and 67.4% of the controls were married. However, 
nearly half (43.5%) of the cases were not able to read 
and write, while 30% of the controls had attained 
secondary education. More than two-third (69.6%) of 
the cases and 43.1% of the controls were housewives. 
Even though limited number of study participants 
replied to the question about their income, 34.3% of the 
cases and 12.6% of the controls had less than 1000 
Ethiopian Birr per month (Table 1). 
 
Table1. Socio demographic characteristics of study participants at Tikur Anbessa Specialized Hospital, 
Addis Ababa, Ethiopia, 2019 
   
Variables  Cases Controls 
Residence Frequency  Per cent  Frequency  Per cent  
Urban  163 70.9 174 75.7 
Rural  67 29.1 56 24.3 
Age group (years)     
<40 125 54.3 143 62.2 
40 and above 105 45.7 87 37.8 
Mean age (Mean +SD) 42.83 + 12.06 39.33 + 11.14 
Marital status      
Single 23 10.0 29 12.6 
Married  175 76.1 155 67.4 
Divorced/widowed 32 13.9 46 20.0 
Education level     
Not able to read and write  100 43.5 34 14.8 
Able to read and write 26 11.3 9 3.9 
Primary education 33 14.3 56 24.3 
Secondary education 45 19.6 69 30.0 
College and University 26 11.3 62 27.0 
Occupation      
Housewife 160 69.6 99 43.1 
Government employee 34 14.8 70 30.4 
Private  16 7.0 42 18.2 
Other  20 8.6 19 8.3 
Income (ETB) (N=108)  (N=127)  
< 1000 37 34.3 16 12.6 
1000 -2000 32 29.6 37 29.1 
2001-3000 10 9.3 27 21.3 
Greater than 3000 29 26.9 47 37.0 
 
Haematologic profile of breast cancer cases and 
controls 
Haemoglobin, red blood cells, platelet count and 
packed cell volume: The overall mean values with 
standard deviation of HB, RBC, PCV, of cases were 
(13.1  1.6g/dl, 4.6  0.54 x 1012/L and 38.7  4.5 %, 
respectively and those values for controls were 14.0  
1.3g/dl, 4.8  0.47 x 1012/L, 40.5  3.5%, respectively 
(Table 2). On the other hand, mean platelet count for 
the cases and controls were 323.4  108.1x109/L and 
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Table 2. HB, RBC, platelet count and PCV parameters of cases and controls at Tikur Anbessa  
Specialized Hospital, Addis Ababa, Ethiopia, 2019 
Parameter Cases Controls P – value 
HB (MeanSD) g/dl 13.11.6 14.0 1.3 0.0001 
Minimum HB 8.7 7.3  
Maximum HB 16.4 20.1  
RBC (MeanSD) x 1012/L 4.60.54 4.80.47 0.020 
Minimum RBC 2.84 3.39  
Maximum RBC 6.18 7.12  
Platelet (MeanSD) x 109L 323. 4108.1 282.070.0 0.0001 
Minimum Platelet 110.0 119.0  
Maximum Platelet 827.0 469.0  
PCV (MeanSD) % 38.74.5 40.53.5 0.0001 
Minimum PCV 26.20 24.80  
Maximum PCV 49.20 58.40  
 
Red cell induces. 
 
The overall MCV, MCH and MCHC values were 84.3 
 8.1fl, 29.04.2pg, and 33.7  1.7% for the cases and 
85.7  6.0 fl, 29.5  2.4pg, 34.2  2.5% for the controls 
(Table 3). MCV and MCHC values were significantly 
lower among breast cancer patients (P <0.05) (Table 
3). 
 
Table 3. Red cell indices values of study participants at Tikur Anbessa  
Specialized Hospital, Addis Ababa, Ethiopia, 2019 
Red cell indices parameters  Cases Controls P- value 
MCV, fl (MeanSD) 84.38.1 85.76.0 0.042 
Minimum MCV 65.6 62.4  
Maximum MCV 105.9 111.5  
MCH, pg (MeanSD) 29.04.2 29.52.4 0.153 
Minimum MCH 21.2 19.3  
Maximum MCH 37.5 39.2  
MCHC, gm/dl (MeanSD) 33.71.7 34.22.5 0.005 
Minimum MCHC 22.4 29.4  
Maximum MCHC 38.5 36.6  
Key= MCV = Mean Cell Volume; MCH= Mean Cell Haemoglobin, MCHC= Mean Cell Haemoglobin 
Concentration, SD= Standard deviation, fl = femtoliter, pg = pico gram 
 
Total WBC and WBC differential parameters: In this 
study, the mean value of total WBC was 7.1  2.8 and 
7.1  2.4 x 109/L for cases and controls, respectively. 
The mean neutrophil, lymphocyte, monocyte and 
eosinophil counts (55.19  13.96%, 29.67  11.21%, 
10.14  5.54%, and 4.05  4.65%, respectively) of the 
cases were, significantly higher than the mean counts 
for the controls, which were 36.39  19.27%, 24.58  
8.40%, 5.51  2.08%, and 2.80  3.88%, respectively.  
Characterization of some selected hematologic 
parameters: In this study, 20.4% of the cases and 
5.6% of the controls were anaemic based on their 
haemoglobin value. Based on severity of anaemia, 
11.7% of the cases and 1.7% of the controls were 
moderately anaemic. On the other hand, 8.7% of the 
cases and 3.5% of the controls were mildly anaemic 
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Table 4. Distribution of abnormal haemoglobin, leucocyte and platelet values between breast 
cancer cases and controls at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2019 
Parameters  Cases Controls   P - value 
Haemoglobin (gm/dl) N % N %  
 
0.0001 
12 and above (No anaemia)  183 79.6 217 94.3 
Mild anaemia 20 8.7 8 3.5 
Moderate anaemia 27 11.7 4 1.7 
Severe anaemia  0 0 1 0.4 
Microcytic anaemia 64 28.2 42 18.4  
0.046 Macrocytic anaemia 2 0.9 3 1.3 
Hypochromic anaemia 15 6.6 8 3.5 0.134 
Normocytic anaemia 23 10.0 7 3.0 0.003 
Normochromic anaemia 27 11.7 9 3.9 0.002 
Microcytic Hypochromic 9 3.9 4 1.7 0.159 
Leucopoenia   13 5.7 9 3.9 0.681 
Normal  198 86.1 202 87.8 
Leucocytosis 19 8.3 19 8.3 
Thrombocytopenia 4 1.7 5 2.2  
0.0001 Normal  172 74.8 207 90 
Thrombocytosis  54 23.5 18 7.8 
Both anaemic and thrombocytosis 16 7.0 1 0.4 0.0001 
Both anaemic, thrombocytosis and leucocytosis 5 2.2 0 0.0 0.025 
 
*The reference range is based on the WHO classification of anaemia. Regarding leucocyte and platelet, the 
reference range is based on the established range of the CBC Sysmex KX – 21N haematology analyser. 
*Anaemia, When HB<12gm/dl, (Mild anaemia when HB is 10.9-11.0 gm/dl, Moderate anaemia when HB is 8.0-
10.9 gm/dl, and Severe anaemia when HB is <8 gm/dl) 
* Leucocytosis: when total WBC count is >10.4 x 109/L, Leucopoenia: when total WBC count is < 3.7 x 109/L. 
 
Out of the total anaemic study participants, 33.3% of 
the cases and 13.3% of the controls were mildly 
anaemic. Moderately anaemic participants accounted 
for 45% of the cases and 6.7% of the controls.  Only 




*Classification of Anaemia: When HB<12gm/dl, (Mild anaemia when HB is 10.9-11.0 gm/dl, Moderate anaemia, 
when HB is 8.0-10.9 gm/dl, and Severe anaemia when HB is <8 gm/dl) 
 
Figure 1. Severity of anaemia among breast cancer cases and controls at Tikur Anbessa Specialized 
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Regarding characterisation of anaemia, microcytic 
anaemia was found among 28.2% of the cases and 
18.4% of the controls. However, microcytic anaemia 
was found among 0.9% of the cases and 1.3% of the 
controls. Similarly, 6.6% of the cases and 3.5% of the 
controls had hypochromic anaemia. It was also found 
that 10.5% of the cases and 3% of the controls were 
with normocytic anaemia; 11.7% of the cases and 3.9% 
of the controls were with normochromic anaemia and 
3.9% of the cases and 1.7% of the controls were with 
microcytic hypochromic anaemia (Table 4). 
Thrombocytosis was found among 23.5% of the cases 
and 7.8% of the controls (P=0.0001) (Table 4). The 
finding also indicated that 7.0% of the cases and 0.4% 
of the controls were both anaemic and with 
thrombocytosis (P=0.0001). Similarly, 2.2% of the 
cases and none of the controls had the triple burden of 
anaemia, leucocytosis, and thrombocytosis (Table 4). 
 
Discussion  
Breast cancer is a major public health problem among 
women both in developed and developing countries. Its 
incidence is rapidly increasing [1-3]. In general, 
different socio demographic and hematologic 
characterisations are important and should be 
considered to maximise treatment success and patient 
survival. In this study, 54.3% of the study participants 
were less than 40 years of age. This finding is 
comparable with different studies conducted in 
Ethiopia [11,12, 25] but not with a study conducted in 
Iraq [20]. This difference could be due to lifestyle, diet, 
genetic characteristics, population characteristics and 
related factors. Even though breast cancer incidence is 
supposed to be higher in above 50 years of age, in this 
study, 15.2% of cases were found to be less than 30 
years old, which is comparable with another study done 
in Ethiopia [25].  However, this study is incomparable 
with a study done in India, which indicated that there is 
no breast cancer case among those that were under 30 
years of age; this difference, could be due to lifestyle, 
genetic factors, and the population distribution of the 
country [21]. In general, this study revealed that the 
majority (that is 76.5%) of breast cancer patients were 
less than 50 years old. This finding is somehow 
comparable with a study done in Pakistan [26]. 
 
Regarding educational status, 43.5% of the cases and 
14.8% of the controls were not able to read and write. 
This result is not comparable with findings reported in 
Sindh.  The difference could be due to smaller sample 
size and study setting (26). In general, large proportion 
(34.3%) of cases as opposed to 12.6% of the controls 
had a monthly income of less than 2000 Ethiopian Birr. 
However, another study indicated that the prevalence 
of breast cancer was higher among socioeconomically 
better off individuals, presumably due to lifestyle risks 
they are exposed to [27]. The majority (i.e., 76.1%) of 
the cases were married. That seems to be consistent 
with results of studies done in Bagdad and Pakistan [6, 
26].  
 
Haematological parameters are examinations which are 
usually accessible with minimum costs. These 
parameters provide helpful evidence regarding many 
types of illnesses, including cancer [20]. This study 
found that the mean HB, PCV, and RBC counts were 
significantly lower in patients than in controls. This 
finding is consistent with studies done in Iraq [20], 
Nigeria [18], and Sindah [26].   
 
Since HB and PCV are used as guides to diagnose 
anaemia, which is one of the major problems among 
most of the cancer patients, those parameters were 
usually lower for the cases than for the healthy controls 
[18, 26]. This low level of haematological parameters 
may be associated with bone marrow or immune 
suppression, because of the cancer itself [18]. The 
other possible reason could be if the patients were on 
pre- or post-surgery conditions, these parameters can 
be significantly reduced. In addition, nutritional status 
and clinical conditions of patients could also play 
important role in the reduction of such values [28, 29]. 
The mean MCV and MCHC were significantly lower 
among cases than among controls. This finding is in 
conformity with results of a study done in Nigeria [19]. 
Except for MCH, it is also supported by a study done 
in India [30].  
 
The mean platelet count was significantly higher 
among patients than controls. This finding is 
comparable with similar studies done in India and 
Nigeria [16, 19]. This increment could be explained by 
the reactive thrombocytosis among most breast cancer 
patients because of cancer-induced anaemia. However, 
this finding is divergent from results of similar study 
conducted in Iraq [20]. This difference could be due to 
small sample size, clinical characteristics, and 
demographic differences of the study participants. In 
this study, the mean neutrophil and lymphocyte counts 
were higher among the cases than with the controls, 
and the higher counts could be explained by neoplasm 
of cancer cells. This finding is consistent with a study 
conducted in Nigeria [19]. In this study, anaemia was 
found in 20.4% of the cases and 5.6% of the controls, a 
result which conforms with similar studies conducted 
in Ethiopia and China [31, 32].  
 
In contrast to the current study, researchers from India 
reported that 60% of pre-chemotherapy breast cancer 
patients were anaemic [28]. This inconsistency in the 
findings could be due to smaller sample size of the 
Indian study, due to difference in study set up and 
background of the study participants. This study also 
indicated that leukopenia was found in 5.7% of the 
cases and 3.9% of controls. The finding is nearly 
comparable with a study done in India [33]. 
Thrombocytosis was observed among 23.5% of the 
cases and 7.8% of the controls. This study was also 




This study is a hospital-based investigation; its results 
may not hold for the general population. In addition, 
even though breast physical examination was made by 
experienced physician, physical examination may not 
be sufficient to detect potential breast mass. 
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Conclusion and Recommendations 
This study observed that most of the breast cancer 
patients were young and there were significant 
numbers of breast cancer cases even under the age of 
30 years. More than two-fifths (43%) of breast cancer 
cases were not able to read and write, with low 
monthly income. Regarding haematological 
parameters, the mean haemoglobin, red blood cell 
count, packed cell volume, mean corpuscular volume; 
and mean corpuscular haemoglobin concentration 
values were significantly lower among cases compared 
to controls. On the other hand, some haematological 
parameters like platelet count, neutrophil count, are 
significantly higher among controls. Anaemia and 
thrombocytosis were also observed as major 
hematologic abnormalities among breast cancer 
patients. 
 
Since younger women were highly affected by breast 
cancer, attention should be given by concerned bodies 
for the young population in every aspect of prevention 
and control activities of breast cancer. Since this study 
may not provide representative evidence, it is 
important to conduct further studies with large sample 
size to confirm the findings of this study and design 
appropriate interventions. 
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